Company Overview
| Stock Name | Republic Healthcare Ltd. |
|---|---|
| Stock Code | 08357 |
| Company Full Name | Republic Healthcare Ltd. |
| Industry | 居民服務 |
| Principal Activities | 公司主要在新加坡從事經營醫療診所及提供管理諮詢服務；胡椒貿易；以及醫療保健相關教育業務。 |
| Listing Date | 2018-06-15 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港灣仔灣仔道165–171號樂基中心1402室 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | 開曼群島 |
| Listing Method | 發售以供認購 + 發售以供配售 |
| Listing Board | GEM |
| Website | http://republichealthcare.asia/ |
| Share Registrar | |
| Registrar Contact | (852)2153 1688 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 0.60 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | 0% |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 78,000,000 |
Valuation & Financials
| Market Cap (at Offer Price) | HK$ 312,000,000 |
|---|---|
| Pre-IPO Valuation (Last Round) | To be extracted |
| P/E Ratio | To be extracted |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 0.79 |
|---|---|
| First Day Open | HK$ 0.65 |
| First Day Change | 31.67% |
| First Day Volume | 193155000.0 |
| First Day Turnover | 146948000.0 |
Use of Proceeds
| Use of Proceeds | 1、約2.6百萬新加坡元或所得款項凈額約28.5%將用于策略性地拓展及鞏固DTAP診治中心的網絡； 2、約1.4百萬新加坡元或所得款項凈額約15.7%將用于增設新SA診治中心； 3、約4.3百萬新加坡元或所得款項凈額約46.9%用于持續吸納及挽留醫生和員工人才； 4、約0.6百萬新加坡元或所得款項凈額約6.4%將用于提升及改善信息科技基礎設施與系統； 5、約0.1百萬新加坡元或所得款項凈額約1.1%將用作設立中央藥庫； 6、約0.1百萬新加坡元或所得款項凈額約1.4%將用作一般營運資金。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
Titan Financial Services Limited CE BFR957
Joint Bookrunners (3)
兴证国际融资有限公司 CE BAK956
讯汇证券有限公司
Titan Financial Services Limited CE BFR957
Joint Lead Managers (3)
兴证国际融资有限公司 CE BAK956
讯汇证券有限公司
Titan Financial Services Limited CE BFR957
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 陳致暹 |
|---|---|
| Company Secretary | 鄧振邦 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 陳致暹(56.09%);Liu Hewen(8.43%) |
|---|
